erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.
..
friday, 18 may, 2018.
.
.
.
..
classifieds
.consider making a donation to support the coverage that shapes the face of berkeley.., and bones, and it�s not clear how the drugs will affect them after long-term use...